Found: 31
Select item for more details and to access through your institution.
Erratum.
- Published in:
- 2007
- By:
- Publication type:
- Correction notice
Utility of reverse phase protein arrays: Applications to signalling pathways and human body arrays.
- Published in:
- Briefings in Functional Genomics & Proteomics, 2002, v. 1, n. 3, p. 305, doi. 10.1093/bfgp/1.3.305
- By:
- Publication type:
- Article
An approach to proteomic analysis of human tumors.
- Published in:
- Molecular Carcinogenesis, 2000, v. 27, n. 3, p. 158, doi. 10.1002/(SICI)1098-2744(200003)27:3<158::AID-MC2>3.0.CO;2-2
- By:
- Publication type:
- Article
Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: Potential for new biomarkers to aid in the diagnosis of breast cancer.
- Published in:
- Disease Markers, 2001, v. 17, n. 4, p. 301, doi. 10.1155/2001/674959
- By:
- Publication type:
- Article
Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM).
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 7, doi. 10.3390/cancers13010007
- By:
- Publication type:
- Article
Signal pathway profiling of prostate cancer using reverse phase protein arrays.
- Published in:
- Proteomics, 2003, v. 3, n. 11, p. 2142, doi. 10.1002/pmic.200300598
- By:
- Publication type:
- Article
Mitochondrial proteome: Altered cytochrome c oxidase subunit levels in prostate cancer.
- Published in:
- Proteomics, 2003, v. 3, n. 9, p. 1801, doi. 10.1002/pmic.200300461
- By:
- Publication type:
- Article
New approaches to proteomic analysis of breast cancer.
- Published in:
- Proteomics, 2001, v. 1, n. 10, p. 1205, doi. 10.1002/1615-9861(200110)1:10<1205::AID-PROT1205>3.0.CO;2-X
- By:
- Publication type:
- Article
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients.
- Published in:
- Oncologist, 2017, v. 22, n. 1, p. 25, doi. 10.1634/theoncologist.2016-0229
- By:
- Publication type:
- Article
Monitoring cancer through the blood.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Cell-Free DNA in Oncology: Gearing up for Clinic.
- Published in:
- Annals of Laboratory Medicine, 2018, v. 38, n. 1, p. 1, doi. 10.3343/alm.2018.38.1.1
- By:
- Publication type:
- Article
Protein microarray platforms for clinical proteomics.
- Published in:
- Proteomics - Clinical Applications, 2007, v. 1, n. 9, p. 934, doi. 10.1002/prca.200700154
- By:
- Publication type:
- Article
Detection of EGFR mutations in non-small cell lung cancer by droplet digital PCR.
- Published in:
- PLoS ONE, 2022, p. 1, doi. 10.1371/journal.pone.0264201
- By:
- Publication type:
- Article
Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells.
- Published in:
- Nature Immunology, 2003, v. 4, n. 1, p. 87, doi. 10.1038/ni871
- By:
- Publication type:
- Article
Realizing the Potential of Plasma Genotyping in an Age of Genotype-Directed Therapies.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 8, p. 1, doi. 10.1093/jnci/dju214
- By:
- Publication type:
- Article
Serum proteomic patterns for detection of prostate cancer.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 7, p. 1027, doi. 10.1038/s41416-021-01664-8
- By:
- Publication type:
- Article
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Proteomic Technologies to Study Diseases of the Lymphatic Vascular System.
- Published in:
- Annals of the New York Academy of Sciences, 2002, v. 979, n. 1, p. 211, doi. 10.1111/j.1749-6632.2002.tb04881.x
- By:
- Publication type:
- Article
Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip.
- Published in:
- Drug Development Research, 2000, v. 49, n. 1, p. 34, doi. 10.1002/(SICI)1098-2299(200001)49:1<34::AID-DDR6>3.0.CO;2-W
- By:
- Publication type:
- Article
Downstream Signaling Pathways in Mouse Adipose Tissues Following Acute In Vivo Administration of Fibroblast Growth Factor 21.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0073011
- By:
- Publication type:
- Article
Identification of Direct Target Engagement Biomarkers for Kinase-Targeted Therapeutics.
- Published in:
- PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0026459
- By:
- Publication type:
- Article
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.
- Published in:
- Nature Medicine, 2015, v. 21, n. 6, p. 560, doi. 10.1038/nm.3854
- By:
- Publication type:
- Article
Tumor-Derived cGAMP Regulates Activation of the Vasculature.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.02090
- By:
- Publication type:
- Article
Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines.
- Published in:
- Electrophoresis, 2000, v. 21, n. 11, p. 2235, doi. 10.1002/1522-2683(20000601)21:11<2235::AID-ELPS2235>3.0.CO;2-A
- By:
- Publication type:
- Article
Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0075-5
- By:
- Publication type:
- Article
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.
- Published in:
- Oncogene, 2001, v. 20, n. 16, p. 1981, doi. 10.1038/sj.onc.1204265
- By:
- Publication type:
- Article
Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 43, p. 1, doi. 10.1126/scitranslmed.3001065
- By:
- Publication type:
- Article
High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0135365
- By:
- Publication type:
- Article
Atypical Droplet Digital Polymerase Chain Reaction Patterns That Indicate Uncommon but Clinically Actionable EGFR Mutations in Lung Cancer.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2024, v. 148, n. 5, p. 553, doi. 10.5858/arpa.2023-0088-OA
- By:
- Publication type:
- Article